|
TMEM39A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.118200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.016500E-02 |
| Normal-vs-Stage2 |
6.973200E-01 |
| Normal-vs-Stage3 |
7.731900E-02 |
| Normal-vs-Stage4 |
5.914400E-01 |
| Stage1-vs-Stage2 |
1.455430E-01 |
| Stage1-vs-Stage3 |
1.220850E-03 |
| Stage1-vs-Stage4 |
3.778400E-01 |
| Stage2-vs-Stage3 |
3.163400E-01 |
| Stage2-vs-Stage4 |
7.144800E-01 |
| Stage3-vs-Stage4 |
8.948200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.811600E-01 |
| Normal-vs-AfricanAmerican |
4.315400E-01 |
| Normal-vs-Asian |
5.586400E-01 |
| Caucasian-vs-AfricanAmerican |
3.770400E-01 |
| Caucasian-vs-Asian |
4.843000E-01 |
| AfricanAmerican-vs-Asian |
2.593400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.262200E-01 |
| Normal-vs-Female |
1.478250E-02 |
| Male-vs-Female |
1.557970E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.682200E-01 |
| Normal-vs-Extreme_Weight |
1.321150E-01 |
| Normal-vs-Obese |
7.881600E-01 |
| Normal-vs-Extreme_Obese |
1.355030E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.447800E-01 |
| Normal_Weight-vs-Obese |
6.492000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.240200E-01 |
| Extreme_Weight-vs-Obese |
1.521410E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.059600E-01 |
| Obese-vs-Extreme_Obese |
1.948600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.772100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.495800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.894810E-01 |
| Normal-vs-Age(81-100Yrs) |
3.066200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.069700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.430600E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.695800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.617900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.902200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.754400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.543200E-01 |
| Normal-VS-Type2 PRCC |
2.371400E-01 |
| Normal-VS-KIRP CIMP |
3.968400E-02 |
| Normal-VS-Unclassified PRCC |
1.483200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.230000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.047900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.488000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.671900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.674200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.640400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.714610E-01 |
| Normal-vs-N1 |
2.254000E-02 |
| Normal-vs-N2 |
4.264000E-01 |
| N0-vs-N1 |
6.821000E-03 |
| N0-vs-N2 |
3.728400E-01 |
| N1-vs-N2 |
5.460200E-01 |
|
|
